{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-204983","form_type":"8-K","ticker":"RPRX","cik":"0001802768","company_name":"Royalty Pharma plc","filed_at":"2025-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.042043+00:00","generated_at":"2026-05-17T06:31:16.457430+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Royalty Pharma prices $2B senior notes in three tranches: 2031, 2035, 2055","bullets":["$600M 4.450% notes due 2031, $900M 5.200% notes due 2035, $500M 5.950% notes due 2055.","Notes are senior unsecured and guaranteed by Royalty Pharma Holdings Ltd and RP Manager LLC.","Issuance closed September 16, 2025; interest payments begin March 25, 2026.","Underwriters include BofA, Goldman Sachs, J.P. Morgan, Morgan Stanley, and TD Securities."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-204983","json":"https://secwatch.observer/filing/0001193125-25-204983.json","markdown":"https://secwatch.observer/filing/0001193125-25-204983.md","text":"https://secwatch.observer/filing/0001193125-25-204983.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802768/000119312525204983/0001193125-25-204983-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802768/000119312525204983/d58607d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:31:16.457430+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}